The attenuated genotype of varicella-zoster virus includes an ORF0 transitional stop codon mutation

Journal of Virology

Volumn 86, Issue 19, 2012, Pages 10695-10703

  Peters, Geoffrey A ^a   Tyler, Shaun D ^a   Carpenter, John E ^b   Jackson, Wallen ^b   Mori, Yasuko ^c   Arvin, Ann M ^d   Grose, Charles ^b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF IOWA CHILDREN S HOSPITAL   (United States)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DIMERIZATION; ENDOPLASMIC RETICULUM; GENE MUTATION; GENETIC TRANSCRIPTION; GENETIC VARIABILITY; GLYCOSYLATION; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN DOMAIN; RADIOIMMUNOPRECIPITATION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; STOP CODON; VARICELLA ZOSTER VIRUS; VIRUS ATTENUATION; VIRUS GENOME; VIRUS REPLICATION;

ANIMALS; CODON, TERMINATOR; COMPUTATIONAL BIOLOGY; FIBROBLASTS; GENOME, VIRAL; GENOTYPE; HERPESVIRUS 3, HUMAN; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNOPRECIPITATION; MICE; MICE, SCID; MICROSCOPY, CONFOCAL; MOLECULAR SEQUENCE DATA; MUTATION; OPEN READING FRAMES; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATORS; VACCINES, ATTENUATED; VIRAL ENVELOPE PROTEINS;

HERPES ZOSTER; HUMAN HERPESVIRUS 3; SIMPLEXVIRUS;

EID: 84869062180     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01067-12     Document Type: Article

References (38)

1. Arvin AM. 2006. Investigations of the pathogenesis of varicella zoster virus infection in the SCIDhu mouse model. Herpes 13:75-80.
2. Breuer J, Grose C, Norberg P, Tipples G, Schmid DS. 2010. A proposal for acommonnomenclature for viral clades that form the species varicella-zoster virus: summary of VZV Nomenclature Meeting 2008, Barts and the London School of MedicineandDentistry, 24-25 July 2008. J. Gen. Virol. 91:821-828.
3. Brunell PA, Casey HL. 1964. Crude tissue culture antigen for determination of varicella-zoster complement fixing antibody. Public Health Rep. 79:839-842.
4. Carpenter JE, Hutchinson JA, Jackson W, Grose C. 2008. Egress of light particles among filopodia on the surface of varicella-zoster virus-infected cells. J. Virol. 82:2821-2835.
5. Cohrs RJ, Gilden DH, Gomi Y, Yamanishi K, Cohen JI. 2006. Comparison of virus transcription during lytic infection of the Oka parental and vaccine strains of varicella-zoster virus. J. Virol. 80:2076-2082.
6. Davison AJ, Scott JE. 1986. The complete DNA sequence of varicellazoster virus. J. Gen. Virol. 67:1759-1816.
7. Drake JW. 1999. The distribution of rates of spontaneous mutation over viruses, prokaryotes, and eukaryotes. Ann. N. Y. Acad. Sci. 870:100-107.
8. Droege M, Hill B. 2008. The Genome Sequencer FLX System-longer reads, more applications, straight forward bioinformatics and more complete data sets. J. Biotechnol. 136:3-10.
9. Duus KM, Hatfield C, Grose C. 1995. Cell surface expression and fusion by the varicella-zoster virus gH:gL glycoprotein complex: analysis by laser scanning confocal microscopy. Virology. 210:429-440.
10. Faga B, Maury W, Bruckner DA, Grose C. 2001. Identification and mapping of single nucleotide polymorphisms in the varicella-zoster virus genome. Virology. 280:1-6.
11. Gershon AA, Arvin AM, Levin MJ, Seward JF, Schmid DS. 2008. Varicella vaccine in the United States: a decade of prevention and the way forward. J. Infect. Dis. 197(Suppl. 2):S39 -S40.
12. Gomi Y, et al. 2002. Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J. Virol. 76:11447-11459.
13. Grose C. 1990. Glycoproteins encoded by varicella-zoster virus: biosynthesis, phosphorylation, and intracellular trafficking. Annu. Rev. Microbiol. 44:59-80.
14. Grose C. 3 July 2012. Pangaea and the out-of-Africa model of varicellazoster virus evolution and phylogeography. J. Virol. doi:10.1128/JVI.00357-12.
15. Grose C, et al. 2004. Complete DNA sequence analyses of the first two varicella-zoster virus glycoprotein E (D150N) mutant viruses found in North America: evolution of genotypes with an accelerated cell spread phenotype. J. Virol. 78:6799-6807.
16. Kaufer BB, Smejkal B, Osterrieder N. 2010. The varicella-zoster virus ORFS/L (ORF0) gene is required for efficient viral replication and contains an element involved in DNA cleavage. J. Virol. 84:11661-11669.
17. Kemble GW, et al. 2000. Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells. J. Virol. 74: 11311-11321.
18. Kim JI, et al. 2011. Sequencing and characterization of Varicella-zoster virus vaccine strain SuduVax. Virol. J. 8:547. doi:10.1186/1743-422X-8-547.
19. Koshizuka T, et al. 2002. Identification and characterization of the UL56 gene product of herpes simplex virus type 2. J. Virol. 76:6718-6728.
20. Koshizuka T, Ota M, Yamanishi K, Mori Y. 2010. Characterization of varicella-zoster virus-encoded ORF0 gene-comparison of parental and vaccine strains. Virology 405:280-288.
21. Moffat JF, et al. 1998. Attenuation of the vaccine Oka strain of varicellazoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J. Virol. 72:965-974.
22. Moriuchi H, Moriuchi M, Smith HA, Cohen JI. 1994. Varicella-zoster virus open reading frame 4 protein is functionally distinct from and does not complement its herpes simplex virus type 1 homolog, ICP27. J. Virol.68:1987-1992.
23. Ng TI, Keenan L, Kinchington PR, Grose C. 1994. Phosphorylation of varicella-zoster virus open reading frame (ORF) 62 regulatory product by viral ORF 47-associated protein kinase. J. Virol. 68:1350-1359.
24. Oxman MN, et al. 2005. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 352:2271-2284.
25. Perera LP, et al. 1993. A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domain. J. Virol. 67:4474-4483.
26. Peters GA, et al. 2006. A full-genome phylogenetic analysis of varicella-zoster virus reveals a novel origin of replication-based genotyping scheme and evidence of recombination between major circulating clades. J. Virol. 80:9850-9860.
27. Rueden CT, Eliceiri KW. 2007. Visualization approaches for multidimensional biological image data. Biotechniques 43(1 Suppl):31, 33-36.
28. Ruyechan WT. 2010. Roles of cellular transcription factors in VZV replication. Curr. Top. Microbiol. Immunol. 342:43-65.
29. Sato B, et al. 2003. Mutational analysis of open reading frames 62 and 71, encoding the varicella-zoster virus immediate-early transactivating protein, IE62, and effects on replication in vitro and in skin xenografts in the SCID-hu mouse in vivo. J. Virol. 77:5607-5620.
30. Schuster SC. 2008. Next-generation sequencing transforms today's biology. Nat. Methods 5:16-18.
31. Storlie J, Carpenter JE, Jackson W, Grose C. 2008. Discordant varicellazoster virus glycoprotein C expression and localization between cultured cells and human skin vesicles. Virology 382:171-181.
32. Storlie J, Jackson W, Hutchinson J, Grose C. 2006. Delayed biosynthesis of varicella-zoster virus glycoprotein C: upregulation by hexamethylene bisacetamide and retinoic acid treatment of infected cells. J. Virol. 80:9544-9556.
33. Takahashi M. 2004. Effectiveness of live varicella vaccine. Expert Opin. Biol. Ther. 4:199-216.
34. Tyler SD, et al. 2007. Genomic cartography of varicella-zoster virus: a complete genome-based analysis of strain variability with implications for attenuation and phenotypic differences. Virology 359:447-458.
35. Weller TH. 1983. Varicella and herpes zoster. Changing concepts of the natural history, control, and importance of a not-so-benign virus. N. Engl. J. Med. 309:1434-1440.
36. Yamagishi Y, et al. 2008. Varicella-zoster virus glycoprotein M homolog is glycosylated, is expressed on the viral envelope, and functions in virus cell-to-cell spread. J. Virol. 82:795-804.
37. Zell R, et al. 2012. Sequencing of 21 varicella-zoster virus genomes reveals two novel genotypes and evidence of recombination. J. Virol. 86:1608-1622.
38. Zerboni L, et al. 2005. Analysis of varicella zoster virus attenuation by evaluation of chimeric parent Oka/vaccine Oka recombinant viruses in skin xenografts in the SCIDhu mouse model. Virology 332:337-346.